Three-Month Continuous Positive Airway Pressure (CPAP) Treatment Decreases Total and LDL-Cholesterol Levels but Does Not Affect Serum Homocysteine and Leptin Levels in Patients with Obstructive Sleep Apnoea Syndrome (OSAS) without Co-Existent Ischaemic Heart Disease (IHD) †
Abstract
Share and Cite
Kumor, M.; Bielicki, P.; Przybyłowski, T.; Rubinsztajn, R.; Zieliński, J.; Chazan, R. Three-Month Continuous Positive Airway Pressure (CPAP) Treatment Decreases Total and LDL-Cholesterol Levels but Does Not Affect Serum Homocysteine and Leptin Levels in Patients with Obstructive Sleep Apnoea Syndrome (OSAS) without Co-Existent Ischaemic Heart Disease (IHD). Adv. Respir. Med. 2011, 79, 173-183. https://doi.org/10.5603/ARM.27655
Kumor M, Bielicki P, Przybyłowski T, Rubinsztajn R, Zieliński J, Chazan R. Three-Month Continuous Positive Airway Pressure (CPAP) Treatment Decreases Total and LDL-Cholesterol Levels but Does Not Affect Serum Homocysteine and Leptin Levels in Patients with Obstructive Sleep Apnoea Syndrome (OSAS) without Co-Existent Ischaemic Heart Disease (IHD). Advances in Respiratory Medicine. 2011; 79(3):173-183. https://doi.org/10.5603/ARM.27655
Chicago/Turabian StyleKumor, Marta, Piotr Bielicki, Tadeusz Przybyłowski, Renata Rubinsztajn, Jan Zieliński, and Ryszarda Chazan. 2011. "Three-Month Continuous Positive Airway Pressure (CPAP) Treatment Decreases Total and LDL-Cholesterol Levels but Does Not Affect Serum Homocysteine and Leptin Levels in Patients with Obstructive Sleep Apnoea Syndrome (OSAS) without Co-Existent Ischaemic Heart Disease (IHD)" Advances in Respiratory Medicine 79, no. 3: 173-183. https://doi.org/10.5603/ARM.27655